‘No time like the present’ for Queensland RSV vaccine rollout The college is urging the state to follow Western Australia’s lead with a ‘lifesaving’ immunisation program.
RSV vaccine could ‘change the landscape’ of hospital presentations Western Australia’s $11 million statewide immunisation rollout follows extensive RACGP advocacy around the issue.
RSV vaccine approved by TGA AREXVY will soon be available for patients aged 60 and over, sparking hope it will ease the pressure on Australia’s overflowing hospitals.
New chronic cough advice ‘well worth bookmarking’ A ‘comprehensive’ update to chronic cough advice suggests child‐specific management will improve clinical outcomes.
Ventolin nebules shortage flagged A shortage of the 2.5 mg/2.5 mL salbutamol inhalation solution ampoule is expected from mid next week until August 2024.
Future asthma risk flagged for babies with food allergy Even if the allergy is outgrown, poorer lung function outcomes are more likely by six years of age, a world-first study finds.
First RSV vaccine approved in US The US drugs regulator has given the green light to a new vaccine, which is also under consideration by the TGA in Australia.
Cranberry juice can prevent some recurrent UTIs: Cochrane Review Consuming cranberry reduces the chance of repeat UTIs for women, children, and people more susceptible to them due to medical procedures.
Possible RSV vaccine is ‘very exciting’ Given to pregnant women, the RSV vaccine is shown to prevent severe disease for up to the first six months of life.
Maternal infection may increase childhood leukaemia risk: Study Genital and urinary tract infections had the strongest associations with subsequent leukaemia risk in children, the research found.